Manufacturer Challenges to Contract Pharmacy Arrangements

August 11th, 2020

This is an in-depth review on the challenges 340B entities & contract pharmacies are facing from recent drug manufacturer notices – Merck, Eli Lilly & Sanofi as well as Executive Orders.

Information Discussed
Eli Lilly: Limited Distribution of Cialis
Merck & Sanofi: Requests for Contract Pharmacy Claims Data 
Legal Issues and Practical Implications related to Data Request 
Next Steps for Covered Entities

Peggy Tighe, Principal, Powers Law 

Bill von Oehsen, Principal, Powers Law


Share your concerns,

we’ll deliver a solution.

Industry Leading Software Solutions
Audits & Consulting
340B Education & Support

Contact our team today.